Blocking policies in pharmaceutical transfer lines

Blocking policies in pharmaceutical transfer lines

0.00 Avg rating0 Votes
Article ID: iaor19982278
Country: Netherlands
Volume: 79
Issue: 1
Start Page Number: 323
End Page Number: 347
Publication Date: Mar 1998
Journal: Annals of Operations Research
Authors: ,
Keywords: production: FMS, maintenance, repair & replacement
Abstract:

In this study, we present cases from the pharmaceutical industry involving buffers and blocking. The industry has many dedicated production lines, aseptic transfer lines (production of injectables) and robotic cells (sample preparation in laboratories). In many cases, the lines are fast (500–1000 units/minute) and they are stopped entirely when a machine fails. Also, there are many lines having medium speed which are controlled by using circular, secondary (and dynamic in size at times) buffers. Good Manufacturing Practice forces the industry to work with certain policies such as scapping upon failure as well as stopping the immediate upstream machines while clearing the buffers. We will present analytical results for some of the above scenarios.

Reviews

Required fields are marked *. Your email address will not be published.